Hostname: page-component-745bb68f8f-5r2nc Total loading time: 0 Render date: 2025-02-12T09:01:28.114Z Has data issue: false hasContentIssue false
  • English
  • Français

The Practical Management of Affective Disorders

Published online by Cambridge University Press:  29 January 2018

David M. Shaw
David M. Shaw*
Affiliation:
Department of Psychological Medicine, The Welsh National School of Medicine, Whitchurch Hospital, Cardiff CF4 7XB
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Review Article
Information
The British Journal of Psychiatry , Volume 130 , Issue 5 , May 1977 , pp. 432 - 451
Copyright
Copyright © Royal College of Psychiatrists, 1977 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Angst, J., Webs, P., Grof, P., Baastrup, P. C. & Schou, M. (1970) Lithium prophylaxis in recurrent affective disorders. British Journal of Psychiatry, 116, 606–14.Google Scholar
Amdisen, A. (1975). Monitoring of lithium treatment through determination of lithium concentration. Danish Medical Bulletin, 22, 277–291.Google Scholar
Åsberg, M., Crönholm, B., Sjöqvist, F. & Tuck, D. (1970) Correlation of subjective side effects with plasma concentrations of nortriptyline. British Medical Journal, iv, 18–21.Google Scholar
Åsberg, M., Crönholm, B., Sjöqvist, F. & Tuck, D. (1971) Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal, iii, 331–4.Google Scholar
Baastrup, P. C. & Schou, M. (1967) Lithium as a prophylactic agent. Its effect against recurrent depression and manic-depressive psychosis. Archives of General Psychiatry, 16, 162–72.CrossRefGoogle ScholarPubMed
Barker, J. C. & Baker, A. A. (1959) Deaths associated with electroplexy. Journal of Mental Science, 105, 339–48.Google Scholar
Bellward, G. D. & Morgan, R. G. (1972) Drug interaction with liver microsomal drug metabolizing enzymes: Imipramine and norethindrone. Canadian Federation of Biological Societies, 15, Abstract 63.Google Scholar
Boakes, A. J. (1971) Monoamine oxidase inhibitors— interactions with other drugs and foodstuffs. Prescribers' Journal, 11, 109–15.Google Scholar
Boakes, A. J. (1974) The interaction of MAOI and tricyclic antidepressants with foodstuffs and other drugs. Colloquium on MAOI therapy. Warner Brothers Publication, 82–107.Google Scholar
Braithwaite, R. A., Goulding, R., Theano, G., Bailey, J. & Coppen, A. (1972) Plasma concentration of amitriptyline and clinical response. Lancet, i, 1297–1300.Google Scholar
Broadhurst, A. D. (1970) L-tryptophan verus ECT. Lancet, i, 1392–3.Google Scholar
Carroll, B. J., Mowbray, R. M. & Davies, B. (1970) Sequential comparison of l-tryptophan with ECT in severe depression. Lancet, i, 967–9.Google Scholar
Coppen, A., Gupta, R., Montgomery, S., Ghose, K., Bailey, J., Burns, B. & Deridder, J. J. (1976) Mianserin hydrochloride: a novel antidepressant. British Journal of Psychiatry, 129, 342–5.CrossRefGoogle ScholarPubMed
Coppen, A., Noguera, R., Bailey, J., Burns, B., Swani, M., Hare, E. & Gardner, R. (1971) Prophylactic lithium in affective disorders—a controlled trial. Lancet, ii, 275–9.Google Scholar
Coppen, A., Prange, A. J., Whybrow, P. C., Noguera, R. & Maggs, R. (1972) The comparative antidepressant effect of l-tryptophan with and without attempted potentiation by liothyronine. Archives of General Psychiatry, 26, 234–41.CrossRefGoogle Scholar
Coppen, A., Shaw, D. M. & Farrell, J. P. (1963) Potentiation of the antidepressant effect of a monoamine-oxidase inhibitor by tryptophan. Lancet, i, 79–81.Google Scholar
Coppen, A., Shaw, D. M., Herzberg, B. & Maggs, R. (1967) Tryptophan in the treatment of depression. Lancet, ii, 1178–80.Google Scholar
Crammer, J. L., Scott, B. & Rolfe, B. (1969) Metabolism of 14C-imipramine: II. Urinary metabolites in man. Psychopharmacologia, 15, 207–25.Google Scholar
Cucinell, S. A., Conney, A. H., Sansur, M. & Burns, J. J. (1965) Drug interactions in man: I. Lowering effect of phenobarbital on plasma levels of Bishydroxycoumarin (Dicumarol) and diphenylhydantoin (Dilantin). Clinical Pyarmacology and Therapeutics, 6, 420–9.Google Scholar
Davidson, S. J. (1976) Psychotropic drugs, stress and cardiomyopathies. Communication to British Association for Psychopharmacology, April 1976. See also:Google Scholar
Davidson, S. J. (& Prof. Innes) (1976) Psychotropic drugs, stress and cardiomyopathies. In Stress and the Heart (ed. Wheatley, D.). New York: Raven Press, 1977.Google Scholar
Davis, J. M. (1976) Overview: Maintenance therapy in psychiatry. II. Affective disorders. American Journal of Psychiatry, 133, 1–13.Google ScholarPubMed
Dayton, P. G. & Perel, J. M. (1971) Physiological and physiochemical bases of drug interactions in man. Annals of the New York Academy of Sciences, 179, 67–87.Google Scholar
Dunner, D. L. & Goodwin, F. K. (1972) Effect of l-tryptophan on brain serotonin metabolism in depressed patients. Archives of General Psychiatry, 26, 364–6.Google Scholar
Flemenbaum, A. (1971) Methylphenidate: a catalyst for the tricyclic antidepressants? American Journal of Psychiatry, 128, 239.Google Scholar
Forrest, A., Nicholson, P. & Hewett, A. (1976) A controlled randomized group comparison of the new isoquinoline nomifensine and imipramine in depressive illness. In press.Google Scholar
Forrest, A. (1975) Maprotiline (Ludiomil) in depression: a report on a hospital monitored release study. In Research and Clinical Investigation in Depression (ed. Murphy, J. E.). Northampton: Cambridge Medical Publications Ltd.Google Scholar
Girdwood, R. H. (1974) Death after taking medicaments. British Medical Journal, i, 501–4.Google Scholar
Glassman, A. H. & Platman, S. R. (1969) Potentiation of a monoamine oxidase inhibitor by tryptophan. Journal of Psychiatric Research, 7, 83–8.Google Scholar
Glassman, A. H. (1973) The clinical pharmacology of imipramine. Archives of General Psychiatry, 28, 649–53.Google Scholar
Gram, L. F. & Over⊘, K. F. (1972) Drug interaction: inhibitory effect of neuroleptics on metabolism of tricyclic antidepressants in man. British Medical Journal, i, 463–5.Google Scholar
Gram, L. F. Reisby, N., Ibsen, I., Nagy, A., Dencker, S.J., Beck, P., Petersen, G. O. & Christiansen, J. (1976) Plasma levels and antidepressant effect of imipramine. Clinical Pharmacology and Therapeutics, 19, 318–24.Google Scholar
Grof, P., Schou, N., Angst, J., Baastrup, P. C. & Weis, P. (1970) Methodological problems of prophylactic trials in recurrent affective disorders. British Journal of Psychiatry, 116, 599–603.CrossRefGoogle ScholarPubMed
Gutierrez, J. L. A. & López Ibor Aliño, J. J. (1971) Tryptophan and a MAOI (Nialamide) in the treatment of depression. International Pharmacopsychiatry, 6, 92–7.Google Scholar
Guze, S. B. & Robins, E. (1970) Suicide and primary affective disorders. British Journal of Psychiatry, 117, 437–8.Google Scholar
Hall, P. (1974) Differential diagnosis and treatment of depression in the elderly. Gerontologia Clinic a, 16, 126–36.Google Scholar
Herrington, R. N., Bruce, A., Johnstone, E. C. & Lader, M. H. (1974) A comparative trial of l-tryptophan and ECT in severe depressive illness. Lancet, ii, 731–4.Google Scholar
Herrington, R. N. (1976) Comparative trial of L-tryptophan and amitriptyline in depressive illness. Psychological Medicine, 6, 673–78.Google ScholarPubMed
Hullin, R. P., McDonald, R. & Allsop, M. N. E. (1972) Prophylactic lithium in recurrent affective disorders. Lancet, 1, 1044–6.Google ScholarPubMed
Johnstone, E. C. (1974) The relationship between response to phenalzine and acetylator status in depressed patients. In Colloquium on MAOI Therapy, pp 40–53. William Warner Publication.Google Scholar
Kato, R., Chiesara, E. & Vassanelli, P. (1963) Mechanism of potentiation of barbiturates and meprobamate actions by imipramine. Biochemical Pharmacology, 12, 357–64.Google Scholar
Kay, D. W. K., Fahy, T. & Garside, R. F. (1970) A seven month double-blind trial of amitriptyline and diazepam in ECT treated depressed patients. British Journal of Psychiatry, 117, 667–71.Google Scholar
Kielholz, P. (Ed.) (1972) Depressive Illness: Diagnosis, Assessment, Treatment. Berne: Hans Huber Publishing.Google Scholar
Klerman, G. L., Dimascio, A., Weissman, M., Prusoff, B. A. & Paykel, E. S. (1974) Treatment of depression by drugs and psychotherapy. American Journal of Psychiatry, 131, 186–91.CrossRefGoogle ScholarPubMed
Kopera, H. (1975) Aspects of clinical pharmacology and clinical experiences with Org GB 94. In Depressive Illness and Experiences with a New Antidepressant Drug GB94 (ed. Vossenaar, T.), pp 26–43. Amsterdam: Excerpta Medica.Google Scholar
Kragh-S⊘rensen, P., Åsberg, M. & Eggert-Hansen, C. (1973) Plasma-nortriptyline levels in endogenous depression. Lancet, 1, 113–15.Google Scholar
Lader, M. H. (1976). Clinical psychopharmacology. In Recent Advances in Clinical Psychiatry No. 2 (ed. Granville-Grossman, K.), pp 1–30. Edinburgh: Churchill Livingstone.Google Scholar
Lancet (1965) Leading article: Combining the antidepressant drugs. Lancet, ii, 118.Google Scholar
Lipsedge, M. (1976) Drug treatment. In Recent Advances in Clinical Psychiatry No. a (ed. Granville-Grossman, K.), pp 31–51. Edinburgh: Churchill Livingstone.Google Scholar
Macdonald, M. G. & Robinson, D. S. (1968) Clinical observations of possible barbiturate interference with anticoagulation. Journal of the American Medical Association, 204, 97–100.CrossRefGoogle ScholarPubMed
Mahapatra, S. B. (1975) Short term effects of viloxazine (Vivalan) compared with placebo in depression: a double-blind study. Journal of the International Medical Research, 3, Suppl. (3), 70–4.Google Scholar
Man, P. L. & Chen, D. H. (1973) Rapid tranquillization of acutely psychotic patients with intramuscular haloperidol and chlorpromazine. Psychosomatics, 14, 59–63.Google Scholar
Marshall, E. F. (1976) The myth of phenelzine acetylation. British Medical Journal, ii, 817.Google Scholar
Massey-Stewart, M. (1976) MAOIs and food—fact and fiction. Adverse Drug Reaction Bulletin, no. 58, 200–3 (ed. Davis, D. M.). Consett, Co. Durham: Adverse Drug Reaction Research Unit.Google Scholar
Melia, P. I. (1970) Prophylactic lithium: a double-blind trial in recurrent affective disorders. British Journal of Psychiatry, 116, 621–4.CrossRefGoogle ScholarPubMed
Mindham, R. H. S., Howland, C. & Shepherd, M. (1973) An evaluation of continuation therapy with tricyclic antidepressants in depressive illness. Psychological Medicine, 3, 5–17.Google Scholar
O'Malley, K., Browning, M., Stevenson, I. & Turn-bull, M.J. (1973) Stimulation of drug metabolism in man by tricyclic antidepressants. European Journal of Clinical Pharmacology, 6, 102–6.Google Scholar
Pare, C. M. B. (1963) Potentiation of monoamine-oxidase inhibitors by tryptophan. Lancet, ii, 527–8.Google Scholar
Paykel, E. S., Dimascio, A., Haskell, D. & Prusoff, B. A. (1975) Effects of maintenance amitriptyline and psychotherapy on symptoms of depression. Psychological Medicine, 5, 67–77.CrossRefGoogle ScholarPubMed
Pearce, J. B. & Linford Rees, W. (1974) A double-blind comparison of three times daily and single night dosage of the tricyclic anti-depressant, dothiepin. The Journal of International Medical Research, 2, 12–19.Google Scholar
Pedersen, V. & M⊘ller Nielsen, I. (1975) Hyperthermia in rabbits caused by interaction between MAOIs, antiparkinsonian drugs and neuroleptics. Lancet, ii, 409–11.Google Scholar
Pichot, P., Guelfi, J. & Drefus, J. F. (1975) A controlled multicentre therapeutic trial of viloxazine (Vivalan). Journal of International Medical Research, 3, Suppl. (3), 80–6.Google Scholar
Price, J. (1967) Human polymorphism. Journal of Medical Genetics, 4, 44–67.Google Scholar
Prien, R. F., Klett, C. J. & Caffey, E. M. (1973) Lithium carbonate and imipramine in prevention of affective disorders. Archives of General Psychiatry, 29, 420–5.Google Scholar
Rawlins, M. D. (1974) Variability in response to drugs. British Medical Journal, iv, 91–4.Google Scholar
Schou, M., Amdisen, A. & Baastrup, P. C. (1971) The practical management of lithium treatment. British Journal of Hospital Medicine, 6, 53–60.Google Scholar
Schou, M. & Shaw, D. M. (1973) Lithium in recurrent manic-depressive disorders. The Practitioner, 210, 105–11.Google Scholar
Schuckit, M., Robins, E. & Feighner, J. (1971) Tricyclic antidepressants and monoamine oxidase inhibitors. Combination therapy in the treatment of depression. Archives of General Psychiatry, 24, 509–14.Google Scholar
Seager, C. P. & Bird, R. L. (1962) Imipramine with electrical treatment in depression-controlled trial. Journal of Mental Science, 108, 704–7.Google Scholar
Sethna, E. R. (1974) A study of refractory cases of depressive illness and their response to combined antidepressant treatment. British Journal of Psychiatry, 124, 265–72.CrossRefGoogle Scholar
Shand, D. G. & Oates, J. A. (1971) Metabolism of propanalol by rat liver microsomes and its inhibition by phenothiazine and tricyclic antidepressant drugs. Biochemical Pharmacology, 20, 1720–3.Google Scholar
Stockley, I. (1974) Drug Interactions and their Mechanisms. London: The Pharmaceutical Press.Google Scholar
Wharton, R. N., Perel, J. M., Dayton, P. G. & Malitz, S. (1971) A potential clinical use for methylphenidate with tricyclic antidepressants. American Journal of Psychiatry, 127, 1619–25.Google Scholar
Wheatley, D. (1976) Evaluation of trazodone in the treatment of anxiety. Current Therapeutic Research, 20, 74–83.Google Scholar
Whyte, S. F., Macdonald, A. J., Naylor, G. J. & Moody, J. P. (1976) Plasma concentrations of protriptyline and clinical effects in depressed women. British Journal of Psychiatry, 128, 384–90.CrossRefGoogle ScholarPubMed
Young, J. P. R., Hughes, W. C. & Lader, M. H. (1976) A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. British Medical Journal, i, 1116–18.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.